Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Efficacy and safety of dilpacimab (ABT-165) versus bevacizumab plus FOLFIRI in metastatic colorectal cancer: a phase II study.
Journal: Future oncology (London, England)
Published: August 03, 2022
A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 02, 2021
A prospective trial of stereotactic body radiation therapy for unresectable pancreatic cancer testing ablative doses.
Journal: Journal of gastrointestinal oncology
Published: January 18, 2021
Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase 1b study (GO28440).
Journal: Haematologica
Published: June 09, 2020
Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using UGT1A1 Genotype-Guided Dosing.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 13, 2019
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial.
Journal: The Lancet. Oncology
Published: November 13, 2018
TGFβ receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer.
Journal: Cancer chemotherapy and pharmacology
Published: October 22, 2018
Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: July 31, 2018
A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies.
Journal: Cancer
Published: July 11, 2018
Prospective International Randomized Phase II Study of Low-Dose Abiraterone With Food Versus Standard Dose Abiraterone In Castration-Resistant Prostate Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 29, 2018
Last Updated: 09/26/2026